Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve Fancy who wrote (4472)	6/12/1998 2:28:00 AM
From: scaram(o)uche	of 6136

Apparently there was "huffing, puffing, blow the house down" at the the IMNR annual meeting. This post is from Yahoo...... Items BuySDBio (M/San Diego) Jun 12 1998 1:41AM EDT The following questions were asked after Dr. Carlo's presentation. (Not verbatim.) Since the DSMB extended the Phase III Remune trials is there any chance of receiving an early approval? Dr. Carlo answered, In the early 1990's alot of people thought immune based therapies were going to be the cure for Aids. At that time there was very little concrete data to back -up that opinion and consequently the attention was turned to anti-viral drugs. When the wave of hope turned to the anti-virals they were quickly brought to market. With the data we have now which will be presented at the Geneva conference the attention could move back to immune based therapies. (snip) Between this and the Johnson's statement today in the release, you'd think that somebody at IMNR will be able to WALK to Geneva.... without sinking. :-) Can't wait! Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next